BACKGROUND/OBJECTIVES: Nutrition and dietary supplementation may modulate outcomes in colorectal cancer (CRC) survivors. However, no recent systematic review has focused on randomised controlled trials (RCTs). The aim of this systematic review was to examine the effects of nutritional RCTs in survivors of colorectal adenomas and cancer. SUBJECTS/METHODS: Medline, Embase, Scopus, Web of Science and the Cochrane Library were searched to identify research between April 2006 and January 2014. The primary outcomes were colorectal adenoma and cancer recurrence. Each included study was assessed for risk of bias. A meta-analysis using a random-effects model was performed, in which two or more RCTs investigated the same dietary intervention. RESULTS: Eight completed RCTs, all in colorectal adenoma survivors, were identified, with four investigating the effect of folic acid. A meta-analysis of the four folic acid RCTs showed no statistically significant effect of folic acid on colorectal adenoma recurrence (relative risks = 0.93; 95% confidence interval: 0.69, 1.25). The impact of the remaining completed RCTs, investigating antioxidant supplementation, green tea extract, prebiotic fibre and phytooestrogens/insoluble fibre, could not be reliably estimated because of the limited number and heterogeneity of the interventions. In addition, three heterogeneous ongoing RCTs were identified, investigating green tea (n = 1) and eicosapentaenoic acid (n = 1) in colorectal adenoma survivors and dietary modifications (n = 1) in CRC survivors in remission. CONCLUSIONS: Overall, this systematic review highlights the need for further research, especially in CRC survivors, as we identified no completed and only one ongoing RCT in this population.
INTRODUCTION
Globally, colorectal cancer (CRC) is the third most common cancer and ranks fourth in terms of mortality. 1 Because of earlier diagnosis, improved treatment and increased general life expectancy, the number of CRC survivors is rising. For both colon and rectal cancer, a 5-year survival of 60% has been observed in patients diagnosed between 2005 and 2009 in 22 countries. 2 Despite improvements in survival, it has been estimated that up to 50% of CRC survivors will develop cancer recurrence at some point in their lives. 3 Research on cancer survivorship and nutrition and dietary supplementation is still inconclusive. 4, 5 In 2007, the World Cancer Research Fund (WCRF) and the American Institute of Cancer Research (AICR) found insufficient evidence to support an association between nutrition and dietary supplementation and modified outcomes in cancer survivors, 4 based on results from a systematic review of randomised controlled trials (RCTs) undertaken in 2006. 6 The key reasons for this finding were variable study quality and research heterogeneity in terms of cancer site and exposure that consequently made it difficult to draw conclusions from the results. 4 Conversely, for primary prevention of CRC, the WCRF/AIRC judged there to be convincing evidence from numerous high-quality studies that red and processed meat, alcoholic drinks in men, overall and abdominal fatness and adult attained height increased risk, whereas physical activity and dietary fibre were protective against CRC. 7 Evidence from dietary supplementation studies was too limited to draw conclusions from the results. 7 Therefore, there is a need to establish whether similar or other nutritional factors and dietary supplements have a role in the recurrence of CRC.
We identified two recent reviews in 2010 (ref. 8) and 2013 (ref. 9) that evaluated the effects of diet on recurrence and survival in CRC survivors. Both reported insufficient evidence to support an association between specific foods, nutrients or dietary patterns and CRC recurrence, and only identified observational studies. Three further reviews, two published in 2011 (refs 10, 11) and one prepared for Macmillan Cancer Support in 2010, 12 that included CRC with other cancer sites in their analysis, were also unable to report any site-specific associations for CRC survival because of limited evidence. None of the aforementioned reviews, including the systematic review, 9 were able to identify sufficient studies to undertake any quantitative analyses. We judged it plausible that recent dietary RCTs in CRC survivors had not been identified, as only one of these reviews was systematic 9 and not all had included RCTs in their search criteria. In addition, all of these reviews highlighted a need for further cancer survivor research. Our interest also included patients with a history of pre-malignant colorectal adenomas, 'colorectal adenoma survivors', as a large body of research has been conducted in this population, who are considered to be at an increased risk of developing CRC.
In addition, evidence suggests that there is a high intake of dietary supplements in cancer survivors, with a recent systematic review indicating that 64-81% of cancer survivors use vitamin and mineral supplements 14 despite the lack of evidence to support any beneficial effect on recurrence. 4 Therefore, we aimed to systematically review the literature on RCTs investigating nutritional interventions in CRC survivors in remission and CRC adenoma survivors.
MATERIALS AND METHODS Design
We undertook a systematic review in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis statement 15 and the Cochrane Handbook for Systematic Reviews of Interventions. 16 Search strategy A structured search of Medline, Embase, Scopus, Web of Science and the Cochrane Library was conducted in January 2014. We used Medical Subject Headings (MeSH terms) and title and/or abstract words for CRC OR colorectal adenomatous polyp AND survivor AND nutrition and related terms to identify relevant studies. The full Medline search strategy is shown in Supplementary Figure S1 , which is available online as Supplementary Information. The bibliographies of selected studies, recent reviews and other relevant papers were hand-searched to identify additional eligible RCTs. A search of grey literature was also undertaken to detect the presence of publication bias, and research registers were searched for ongoing trials. The search was restricted to studies since April 2006 to identify those published after the WCRF cancer survivor systematic review search. 6 
Inclusion criteria
The following studies were eligible for inclusion: RCTs, RCT protocols and summaries of ongoing RCTs involving CRC survivors in remission and patients with a history of colorectal adenomas. Nutritional interventions involving dietary changes of macronutrients or micronutrients or a particular food type or any vitamin, mineral or other dietary supplement were included. Eligible outcomes were CRC recurrence and mortality, all-cause mortality, colorectal adenoma recurrence, biomarkers of precancerous cell or tumour progression, disease-free survival and healthrelated quality of life. There was no language restriction to the search.
Exclusion criteria
RCTs that were conducted before or during cancer treatment were excluded because of the confounding effect on outcome of treatment and disease pathology. RCTs involving polymorphisms or other genetic factors that influenced CRC risk were excluded. We also excluded RCTs that investigated the combined effect of diet and physical activity to enable us to assess the specific effect of diet.
Data extraction and risk of bias
Publications were initially screened electronically based on title and abstract (MvD). Full texts were retrieved and examined to decide on their eligibility. One reviewer (MvD) extracted the data from eligible studies including author, year of publication, dietary factor(s) investigated, setting (population, number of centres, country and age), outcome investigated, sample size, treatment, follow-up period and main findings (for completed trials only). Data were also extracted for each completed study to assess the risk of bias, using the recommendations from the Cochrane Handbook. 16 
Data synthesis and analysis
We undertook a meta-analysis using REVMAN 5.2 17 where two or more RCTs investigated the same dietary intervention and when the extracted data provided sufficient information to obtain the mean and s.d. of the sought, continuous outcomes necessary for data pooling. Unpublished data that were required for the meta-analysis were requested directly from the authors. We used a random-effects model to estimate relative risks with 95% confidence intervals, and the Χ 2 -test was used to assess the presence of heterogeneity, with Po0.10 indicating statistical heterogeneity. 16 To assess the level of heterogeneity, the I 2 -test was used, with 50-90% considered to be suggestive of substantial heterogeneity. 16 RCTs with heterogeneous interventions were reviewed narratively. A sensitivity analysis was also performed to exclude data from studies that were assessed as having a high risk of bias.
RESULTS

Search results
The initial search identified 609 unique citations, which were screened electronically by title and abstract ( Figure 1 ). Full-text screening was performed on 19 papers, with eight papers meeting the inclusion criteria. Three further studies were identified from review paper bibliographies (n = 2) and research registers (n = 1).
No foreign language or unpublished completed RCTs were identified. The search identified a total of 11 studies for inclusion in the review: eight completed RCTs published between 2007 and 2013 and three ongoing RCTs.
Characteristics of included studies An overview of the characteristics of the included studies is shown in Table 1 . The eight completed RCTs investigated folic acid (n = 4), [18] [19] [20] [21] multivitamins (n = 1), 22 green tea extract (GTE) (n = 1), 23 prebiotic dietary fibre (n = 1) 24 and phytooestrogens and insoluble fibre (n = 1). 25 All RCTs involved colorectal adenoma survivors. We identified no completed RCT in CRC survivors in remission that met our inclusion criteria. The ongoing interventions investigated green tea (n = 1) 26 and eicosapentaenoic acid (n = 1) 27 in colorectal adenoma survivors and dietary changes (n = 1) in CRC survivors in remission, with the effect of physical activity assessed in a separate group. 28 Characteristics of completed studies The selected studies were undertaken in North America (n = 4), 18, 20, 21, 24 Europe (n = 3) 19, 22, 25 and Asia (n = 1). 23 Five studies were multi-centred, 18, 19, [22] [23] [24] two were single-centred 20, 25 and one was conducted by mail. 21 More men than women were included in the studies (with the exception of one), 21 reflecting the higher incidence of CRC in men. Mean age was between 57 and 65 years. Six studies had colorectal adenoma recurrence as their main outcome. [18] [19] [20] [21] [22] [23] Two studies investigated biomarkers of abnormal cell progression. 24, 25 Qualitative analysis Folic acid supplementation. There was heterogeneity in the dosage of folic acid supplementation between studies with 0.5 mg/day, 19 1 mg/day 18,21 and 5 mg/day. 19 Two studies investigated aspirin in conjunction with folic acid. 18, 19 The duration of treatment was 3 years, 19 ,20 5-6.5 years 21 and 6-8 years (split into two phases of 3 years and 3-5 years). 18 Our analysis of the study by Cole et al., 18 only related to the first 3 years phase as the results for the folic acid and placebo groups, without aspirin, were not reported for the second phase.
Antioxidant supplementation. One study by Bonelli et al. 22 investigated the effect of multivitamin supplementation on colorectal adenoma recurrence. The study reported a statistically significant reduction in colorectal adenoma recurrence with antioxidant supplementation (selenium, zinc, vitamin A, C and E) versus a placebo (adjusted hazards ratio = 0.61; 95% confidence interval (CI): 0.41, 0.92).
Green tea extract supplementation. One study investigated the effect of GTE on colorectal adenoma recurrence, reporting a statistically significant reduction in the intervention group (relative risks = 0.49; 95% CI: 0.24, 0.99) in subjects who completed the RCT. 23 However, an intention-to-treat analysis found no significant difference between the two groups.
Prebiotic dietary fibre supplementation. A 6-month trial compared the effects of prebiotic dietary fibre with two other interventions (a statin and a nonsteroidal anti-inflammatory drug) and a placebo. 24 No significant difference was observed in the percentage change in the number of rectal aberrant crypt foci between the dietary fibre and control group (−3.6% (95% CI: − 88 to 83%) versus − 10% (−100 to 117%), P = 0.92, median value (range) of %ΔACF). There was also no significant difference in biomarkers of proliferation (Ki67) or apoptosis (caspase-3) between groups (P40.05).
Phytooestrogens and insoluble dietary fibre supplementation.
A 60-day trial with 60 participants investigated the effects of a dietary intervention of phytooestrogens and insoluble fibre. 25 The authors reported a statistically significant increase in the estrogen receptor beta protein in the intervention group versus the control group (0.82 ± 0.08 versus 0.77 ± 0.10; P = 0.04), a potential biomarker of CRC that decreases during disease progression, suggestive of a protective effect. No statistically significant differences were observed in the expression of any other estrogen receptor proteins or messenger RNA.
Quantitative analysis A meta-analysis was performed on four folic acid studies. [18] [19] [20] [21] One study did not publish sufficient data necessary for meta-analysis. 20 However, the necessary data were acquired indirectly from another published systematic review, 29 as it was not provided by the authors. The four studies included a total of 1615 subjects and 444 cases of colorectal adenoma recurrence. Three studies were large-scale trials, 18, 19, 21 which individually randomised 339, 18 467 (Ref. 19) and 672 subjects 21 to either folic acid or placebo groups (without aspirin). The fourth study was smaller with a total of 137 randomised subjects. 20 The meta-analysis showed no significant association between folic acid and colorectal adenoma recurrence (relative risks = 0.93; 95% CI: 0.69, 1.25; Figure 2 ). As substantial heterogeneity was observed between the four studies (I 2 = 71%), a sensitivity analysis was performed to exclude the Jaszewski et al. 20 trial. Justification for this exclusion included the small number of study participants, the high dosage of folic acid compared with other studies (5 mg/day versus 0.5-1 mg/day) and the higher risk of bias (see below). The sensitivity analysis also found a nonsignificant association between folic acid and colorectal adenoma recurrence, but the direction of the association was reversed (relative risks = 1.06; 95% CI: 0.87, 1.29). Figure 1 . Flowchart of the search and selection process for articles included in the systematic review of randomised controlled trials investigating the effects of nutritional interventions in survivors of colorectal cancer and colorectal adenomas. HNPCC, hereditary nonpolyposis colorectal cancer; HR: hazard ratio; NSAID, nonsteroidal anti-inflammatory drugs; RR, relative risk.
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Risk of bias The risk of bias of included studies in relation to specific criteria is summarised in Supplementary Table S1 , which is available online as Supplementary Information. No study was assessed as risk free, generally because of a lack of included information rather than specific evidence suggestive of a trial being high risk. Most studies indicated how the participants had been randomised, with the exception of one. 25 Only one study failed to provide data for an intention-to-treat analysis. 22 However, power calculations were omitted from three studies, 20, 21, 23 with only one study adequately powered. 18 Of the folic acid RCTs, the Jaszewski et al. 20 study was considered the lowest-quality trial, with a dropout rate of 31%, discrepancies in the published data and no information provided on power calculations.
DISCUSSION
Our systematic review summarised nutritional interventions in survivors of colorectal adenomas and cancer since 2006 to evaluate the effects on colorectal adenoma and cancer recurrence. We identified eight completed and two ongoing RCTs in colorectal adenoma survivors, but only one ongoing RCT in CRC survivors. Four folic acid RCTs in colorectal adenoma survivors showed no significant effect on colorectal adenoma recurrence (P40.05) when meta-analysed. The remaining RCTs in colorectal adenoma survivors were too limited and heterogeneous to enable conclusions to be drawn about their effect. However, the ongoing RCT in CRC survivors in remission is, to our knowledge, the first RCT in this population that examines the effect of diet separately from physical activity.
We identified a different range of nutritional interventions than reported in the WCRF/AICR systematic review. 6 This was largely because of our focus on CRC survivors in remission and the inclusion of biomarkers of pre-cancerous cell or tumour progression, which we considered realistic outcomes given the time frame for cancer development. Our meta-analysis on the association between folic acid and colorectal adenoma recurrence confirmed the findings of three recently published systematic reviews that found no significant association between folic acid and overall adenoma recurrence. [29] [30] [31] Two of the four completed non-folic acid RCTs that we identified (phytooestrogen/insoluble fibre and antioxidants) demonstrated a reduced risk of recurrence, warranting additional larger scale studies to replicate the results. However, the WCRF/AICR review identified six antioxidant RCTs that when meta-analysed showed no significant effect on colorectal adenoma recurrence (OR: 0.63; 95% CI: 0.36-1.12) with high heterogeneity between studies (I 2 = 78.2). 6 In fact, the WCRF/AICR advise against dietary supplement intake for both primary cancer prevention and for cancer survivors. 2 Our systematic review identified one completed GTE RCT 23 that reported a reduction in colorectal adenoma recurrence, but the statistical significance was lost when an intention-to-treat analysis was performed. In animal studies, GTE has been shown to reduce the number and growth rate of colorectal adenomas in the Apc min mouse, a model for colorectal adenoma development. 32, 33 However, excluding the RCTs identified in the current review, evidence in humans is still limited to observational studies examining the link with primary CRC prevention with a recent Cochrane narrative review reporting that the evidence was too limited and conflicting to base recommendations on. 34 Studies have also been undertaken in Asia where baseline green tea consumption is high. 34, 35 The ongoing GTE RCT we identified is taking place in Germany 26 and excludes patients with moderate or high green tea consumption. It will therefore provide the highestquality evidence to date to support any effect of green tea consumption on colorectal adenoma recurrence in a European population.
Interestingly, all completed studies that we identified involved dietary supplementation interventions. However, the effect of supplements can be highly confounded by the lifestyle habits of intervention subjects and more specifically the intake of the assessed nutrient in their diet. 36 In addition, the effect of the supplement may differ depending on the dosage and timing of the intervention. Folic acid has been reported to impair carcinogenesis in pre-cancerous cells but promote it in established cancer cells in animal studies. 37 These factors could collectedly explain the difference in the direction of the effect between studies (see Figure 2) , particularly if some of the subjects had undetected colorectal carcinomas.
Our review had a number of limitations. First, only one researcher was involved in the search process, and thus eligible studies may have been missed. Similarly, the assessment of risk of bias was made by one researcher; another researcher may have evaluated the studies differently. These limitations were partially circumvented by consulting a second researcher (GKP) at regular intervals for guidance on any areas of uncertainty. Despite the search of grey literature, it is also possible that unpublished studies, which are frequent in cancer, were not identified. 38 In addition, we did not exclude studies based on methodological quality, as we expected that this criterion would severely limit the search results. Our meta-analysis used summary statistics rather than individual level data, and thus we relied on the accurate statistical analysis and reporting of the primary data by the original researchers. Finally, our focus on RCTs may have limited our search results through not being the most widely used study design in CRC survivors. Although meta-analyses of RCTs are generally ranked as the highest level of clinical evidence, the WCRF/AICR 39 and others 40 regard epidemiology, particularly longitudinal prospective cohort studies, as a more relevant study design for identifying the aetiology of a disease. However, two recent reviews 8, 9 that included observational research in their search criteria failed to identify any observational studies in CRC survivors in remission, suggesting that research in this population is limited across all study designs.
Our review had a number of strengths. The focus on CRC survivors in remission and colorectal adenoma survivors is highly relevant in the context of public health, given the increase in the number of CRC survivors living beyond 5 years 3 and also the high incidence of CRC. 1 A systematic approach to identify trials and Figure 2 . Risk of adenoma recurrence with folic acid supplementation based on RevMan results. 16 Systematic review diet and CRC survivors M van Dijk and GK Pot critically assess their risk of bias was used and the search strategy used a comprehensive, well-researched list of search terms and included four key databases (Medline, Embase, Scopus and Web of Science) and the Cochrane Library. The inclusion of ongoing RCTs in our search criteria was another strength, as it highlighted the only RCT in CRC survivors in remission and other highly relevant ongoing RCTs that were not included in previous reviews. By highlighting the paucity of RCTs in CRC survivors, our review underlined the need for additional primary research in this population. This is highly relevant in the context of the more abundant research that is available for other types of cancer, most notably breast and prostate.
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Future research is warranted in CRC survivors in remission focusing on food-based interventions, as most research to date has investigated vitamin, mineral and other types of supplementation in colorectal adenoma survivors. Dietary factors that are linked with modified primary CRC risk could form the basis of future RCTs in CRC survivors to confirm whether the same factors are associated with CRC recurrence. This concept forms the basis of the ongoing RCT that we identified in CRC survivors, which aims to reduce red meat consumption (and refined grains) in CRC survivors in remission. 28 We also identified an as yet unpublished RCT that involves reducing red meat and eliminating processed meat consumption in colorectal adenoma survivors (ISRCTN: 03320951), which assesses compliance, and, if successful, an RCT assessing colorectal adenoma recurrence will follow. In addition, as isolating the effects of specific foods or nutrients is challenging because of their interaction with other dietary components, this could be circumvented through investigating the effects of healthy dietary patterns in an RCT design in CRC survivors. In prospective cohort studies, westernised dietary patterns have been associated with an increased risk of primary CRC in the general population 41, 42 and poorer disease-free survivals in CRC survivors recruited during chemotherapy. 43 In conclusion, there is currently insufficient evidence that dietary interventions modify CRC recurrence in CRC survivors or adenoma recurrence in colorectal adenoma survivors. Although our systematic review identified one ongoing RCT in CRC survivors in remission, overall it highlighted the need for further research especially in CRC survivors in remission. The results from such research will provide valuable information to evaluate whether dietary factors relevant to primary CRC prevention have a similar effect on CRC recurrence.
